The model to estimate survival for hepatocellular carcinoma (MESH) staging system is proposed and validated in this study.
The MESH score contains large tumour, vascular invasion or metastasis, child score, performance, alpha-fetoprotein and alkaline phosphatase.
This newly proposed simple and accurate survival model provides enhanced prognostic accuracy for HCC.